» Articles » PMID: 35937651

Notifiable Infectious Diseases Among Organ Transplant Recipients: A Data-Linked Cohort Study, 2000-2015

Abstract

Background: Infections, including common communicable infections such as influenza, frequently cause disease after organ transplantation, although the quantitative extent of infection and disease remains uncertain.

Methods: A cohort study was conducted to define the burden of notifiable infectious diseases among all solid organ recipients transplanted in New South Wales, Australia, 2000-2015. Data linkage was used to connect transplant registers to hospital admissions, notifiable diseases, and the death register. Standardized incidence ratios (SIRs) were calculated relative to general population notification rates, accounting for age, sex, and calendar year. Infection-related hospitalizations and deaths were identified.

Results: Among 4858 solid organ recipients followed for 39 183 person-years (PY), there were 792 notifications. Influenza was the most common infection (532 cases; incidence, 1358 [95% CI, 1247-1478] per 100 000 PY), highest within 3 months posttransplant. Next most common was salmonellosis (46 cases; incidence, 117 [95% CI, 87-156] per 100 000 PY), then pertussis (38 cases; incidence, 97 [95% CI, 71-133] per 100 000 PY). Influenza and invasive pneumococcal disease (IPD) showed significant excess cases compared with the general population (influenza SIR, 8.5 [95% CI, 7.8-9.2]; IPD SIR, 9.8 [95% CI, 6.9-13.9]), with high hospitalization rates (47% influenza cases, 68% IPD cases) and some mortality (4 influenza and 1 IPD deaths). By 10 years posttransplant, cumulative incidence of any vaccine-preventable disease was 12%, generally similar by transplanted organ, except higher among lung recipients. Gastrointestinal diseases, tuberculosis, and legionellosis had excess cases among transplant recipients, although there were few sexually transmitted infections and vector-borne diseases.

Conclusions: There is potential to avoid preventable infections among transplant recipients with improved vaccination programs, health education, and pretransplant donor and recipient screening.

Citing Articles

Pneumonia in Transplant Recipients: A Comprehensive Review of Diagnosis and Management.

Pata R, Kristeva J, Kosuru B Cureus. 2024; 16(11):e73669.

PMID: 39544950 PMC: 11562015. DOI: 10.7759/cureus.73669.


Psittacosis: An Underappreciated and Often Undiagnosed Disease.

Dembek Z, Mothershead J, Owens A, Chekol T, Wu A Pathogens. 2023; 12(9).

PMID: 37764973 PMC: 10536718. DOI: 10.3390/pathogens12091165.


Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.

Subramanian V J Infect Dis. 2023; 228(Suppl 1):S34-S45.

PMID: 37539762 PMC: 10401623. DOI: 10.1093/infdis/jiad152.


Rarely Encountered Gram-Negative Rods and Lung Transplant Recipients: A Narrative Review.

Farfour E, Roux A, Sage E, Revillet H, Vasse M, Vallee A Microorganisms. 2023; 11(6).

PMID: 37374970 PMC: 10305300. DOI: 10.3390/microorganisms11061468.


and : Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations.

Miguelena Chamorro B, De Luca K, Swaminathan G, Longet S, Mundt E, Paul S Clin Microbiol Rev. 2023; 36(3):e0016422.

PMID: 37306571 PMC: 10512794. DOI: 10.1128/cmr.00164-22.


References
1.
Chong P, Avery R . A Comprehensive Review of Immunization Practices in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients. Clin Ther. 2017; 39(8):1581-1598. DOI: 10.1016/j.clinthera.2017.07.005. View

2.
Torre-Cisneros J, Doblas A, Aguado J, San Juan R, Blanes M, Montejo M . Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis. 2009; 48(12):1657-65. DOI: 10.1086/599035. View

3.
San Juan R, Aguado J, Lumbreras C, Diaz-Pedroche C, Lopez-Medrano F, Lizasoain M . Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group. Am J Transplant. 2007; 7(4):964-71. DOI: 10.1111/j.1600-6143.2006.01694.x. View

4.
Kumar D, Humar A, Plevneshi A, Green K, Prasad G, Siegal D . Invasive pneumococcal disease in solid organ transplant recipients--10-year prospective population surveillance. Am J Transplant. 2007; 7(5):1209-14. DOI: 10.1111/j.1600-6143.2006.01705.x. View

5.
Chadban S, Chan M, Fry K, Patwardhan A, Ryan C, Trevillian P . The CARI guidelines. Food safety recommendations for adult kidney transplant recipients. Nephrology (Carlton). 2010; 15 Suppl 1:S35-6. DOI: 10.1111/j.1440-1797.2010.01230.x. View